Cardiovascular therapeutics

Keyphrases

Publications

volume 2024, 2024

Lu Chen, Hongyu Su, Zekai Tao, Cui Liang, Zhongzhao Liu, Yiming Dong, Peipei Zheng, Yuan Liu
DUSP22 Ameliorates Endothelial-to-Mesenchymal Transition in HUVECs through Smad2/3 and MAPK Signaling Pathways. Cardiovascular therapeutics 2024 (2024)
Yan Zhang, Tian Liu, Ze-Jie Qu, Xue Wang, Wen-Gang Song, Shou-Dong Guo
Laminaria japonica Aresch-Derived Fucoidan Ameliorates Hyperlipidemia by Upregulating LXRs and Suppressing SREBPs. Cardiovascular therapeutics 2024 (2024)
Xiang Huang, Xiao-Lan Li, Heng Zhou, Xiao-Mei Li
Assessment of Angiography-Based Renal Quantitative Flow Ratio Measurement in Patients with Atherosclerotic Renal Artery Stenosis. Cardiovascular therapeutics 2024 (2024)
Lu Chen, Hongyu Su, Zekai Tao, Cui Liang, Zhongzhao Liu, Yiming Dong, Peipei Zheng, Yuan Liu
DUSP22 Ameliorates Endothelial-to-Mesenchymal Transition in HUVECs through Smad2/3 and MAPK Signaling Pathways. Cardiovascular therapeutics 2024 (2024)
Lu Chen, Hongyu Su, Zekai Tao, Cui Liang, Zhongzhao Liu, Yiming Dong, Peipei Zheng, Yuan Liu
DUSP22 Ameliorates Endothelial-to-Mesenchymal Transition in HUVECs through Smad2/3 and MAPK Signaling Pathways. Cardiovascular therapeutics 2024 (2024)
Ibtissam Talha, Noureddine Elkhoudri, Abderraouf Hilali
Major Limitations of Cardiovascular Risk Scores. Cardiovascular therapeutics 2024 (2024)
Ibtissam Talha, Noureddine Elkhoudri, Abderraouf Hilali
Major Limitations of Cardiovascular Risk Scores. Cardiovascular therapeutics 2024 (2024)
Yan Zhang, Tian Liu, Ze-Jie Qu, Xue Wang, Wen-Gang Song, Shou-Dong Guo
Laminaria japonica Aresch-Derived Fucoidan Ameliorates Hyperlipidemia by Upregulating LXRs and Suppressing SREBPs. Cardiovascular therapeutics 2024 (2024)
Yao Yao, Yanli Li, Qinchun Jin, Xiaoye Li, Xiaochun Zhang, Qianzhou Lv
Perioperative Treatment with Rivaroxaban and Dabigatran on Changes of Coagulation and Platelet Activation Biomarkers following Left Atrial Appendage Closure. Cardiovascular therapeutics 2024 (2024)
Yao Yao, Yanli Li, Qinchun Jin, Xiaoye Li, Xiaochun Zhang, Qianzhou Lv
Perioperative Treatment with Rivaroxaban and Dabigatran on Changes of Coagulation and Platelet Activation Biomarkers following Left Atrial Appendage Closure. Cardiovascular therapeutics 2024 (2024)
Xiang Huang, Xiao-Lan Li, Heng Zhou, Xiao-Mei Li
Assessment of Angiography-Based Renal Quantitative Flow Ratio Measurement in Patients with Atherosclerotic Renal Artery Stenosis. Cardiovascular therapeutics 2024 (2024)
Xiang Huang, Xiao-Lan Li, Heng Zhou, Xiao-Mei Li
Assessment of Angiography-Based Renal Quantitative Flow Ratio Measurement in Patients with Atherosclerotic Renal Artery Stenosis. Cardiovascular therapeutics 2024 (2024)

volume 2023, 2023

Xiguang Yang, Xiaopeng Duan, Zhenglin Xia, Rui Huang, Ke He, Guoan Xiang
The Regulation Network of Glycerolipid Metabolism as Coregulators of Immunotherapy-Related Myocarditis. Cardiovascular therapeutics 2023 (2023)
Xiguang Yang, Xiaopeng Duan, Zhenglin Xia, Rui Huang, Ke He, Guoan Xiang
The Regulation Network of Glycerolipid Metabolism as Coregulators of Immunotherapy-Related Myocarditis. Cardiovascular therapeutics 2023 (2023)
Antoine J Ribieras, Yulexi Y Ortiz, Yan Li, Nga T Le, Carlos Theodore Huerta, Francesca A Voza, Hongwei Shao, Roberto I Vazquez-Padron, Zhao-Jun Liu, Omaida C Velazquez
E-Selectin/AAV Gene Therapy Promotes Myogenesis and Skeletal Muscle Recovery in a Mouse Hindlimb Ischemia Model. Cardiovascular therapeutics 2023 (2023)
Xueting Fan, Kai Feng, Yonghui Liu, Leixi Yang, Yizhuo Zhao, Liping Tian, Yiqun Tang, Xiaozhi Wang
miR-135a Regulates Atrial Fibrillation by Targeting Smad3. Cardiovascular therapeutics 2023 (2023)
Huanhuan Wang, Dan Liu, Jidong Guo, Nuerbahati Heisha, Lei Wang, Qiang Zhang, Yihui Han, Xiping Wang, Bo Zhang, Jinqing Yuan, Li-Jian Gao
Analysis of the Efficacy and Safety of Coronary Catheterization through Distal Transradial Access: A Single-Center Data. Cardiovascular therapeutics 2023 (2023)
Zujin Xu, Zhuoran Wei, Yali Zhu, Guoqing Jing, Liufang Chen, Jia Zhan, Yun Wu
Cardioprotection of mAb2G4/ODN/lip on Myocardial Ischemia-Reperfusion Injury via Inhibiting the NF- κ B Signaling Pathway. Cardiovascular therapeutics 2023 (2023)
Maoxia Fan, Guohua Dai, Runmin Li, Xiaoqi Wu
Efficacy of Acupuncture in the Treatment of Essential Hypertension: An Overview of Systematic Reviews and Meta-Analyses. Cardiovascular therapeutics 2023 (2023)
Maoxia Fan, Guohua Dai, Runmin Li, Xiaoqi Wu
Efficacy of Acupuncture in the Treatment of Essential Hypertension: An Overview of Systematic Reviews and Meta-Analyses. Cardiovascular therapeutics 2023 (2023)
Maoxia Fan, Guohua Dai, Runmin Li, Xiaoqi Wu
Efficacy of Acupuncture in the Treatment of Essential Hypertension: An Overview of Systematic Reviews and Meta-Analyses. Cardiovascular therapeutics 2023 (2023)
Maoxia Fan, Guohua Dai, Runmin Li, Xiaoqi Wu
Efficacy of Acupuncture in the Treatment of Essential Hypertension: An Overview of Systematic Reviews and Meta-Analyses. Cardiovascular therapeutics 2023 (2023)
Anwu Huang, Zhaolin Wang, Hua Tang, Zhuyin Jia, Xiaojun Ji, Xuehua Yang, Wenbing Jiang
Bardoxolone Methyl Ameliorates Myocardial Ischemia/Reperfusion Injury by Activating the Nrf2/HO-1 Signaling Pathway. Cardiovascular therapeutics 2023 (2023)
Zujin Xu, Zhuoran Wei, Yali Zhu, Guoqing Jing, Liufang Chen, Jia Zhan, Yun Wu
Cardioprotection of mAb2G4/ODN/lip on Myocardial Ischemia-Reperfusion Injury via Inhibiting the NF- κ B Signaling Pathway. Cardiovascular therapeutics 2023 (2023)
Dishiwen Liu, Huiyu Chen, Yuntao Fu, Yajun Yao, Shanqing He, Youcheng Wang, Zhen Cao, Xuewen Wang, Mei Yang, Qingyan Zhao
KCa3.1 Promotes Proinflammatory Exosome Secretion by Activating AKT/Rab27a in Atrial Myocytes during Rapid Pacing. Cardiovascular therapeutics 2023 (2023)
Runmei Zou, Shuo Wang, Hong Cai, Yuwen Wang, Cheng Wang
Pharmacological Activation of Rev-erb α Attenuates Doxorubicin-Induced Cardiotoxicity by PGC-1 α Signaling Pathway. Cardiovascular therapeutics 2023 (2023)
Runmei Zou, Shuo Wang, Hong Cai, Yuwen Wang, Cheng Wang
Pharmacological Activation of Rev-erb α Attenuates Doxorubicin-Induced Cardiotoxicity by PGC-1 α Signaling Pathway. Cardiovascular therapeutics 2023 (2023)
Xiguang Yang, Xiaopeng Duan, Zhenglin Xia, Rui Huang, Ke He, Guoan Xiang
The Regulation Network of Glycerolipid Metabolism as Coregulators of Immunotherapy-Related Myocarditis. Cardiovascular therapeutics 2023 (2023)
Alana Lalucha Andrade Guimarães, Mansueto Gomes Neto, Lino Sérgio Rocha Conceição, Micheli Bernardone Saquetto, Caroline Oliveira Gois, Vitor Oliveira Carvalho
Water-Based Exercises on Peak Oxygen Consumption, Exercise Time, and Muscle Strength in Patients with Coronary Artery Disease: A Systematic Review with Meta-Analysis. Cardiovascular therapeutics 2023 (2023)
Rasheed K Ibdah, Ahmad Alrawashdeh, Sukaina I Rawashdeh, Nebras Y Melhem, Ayman J Hammoudeh, Mohamad Ismail Jarrah
Statin Eligibility according to 2013 ACC/AHA and USPSTF Guidelines among Jordanian Patients with Acute Myocardial Infarction: The Impact of Gender. Cardiovascular therapeutics 2023 (2023)
Angel López-Candales, Talal Asif, Khalid Sawalha, Nicholas B Norgard
Heart Failure with Preserved Left Ventricular Ejection Fraction: A Complex Conundrum Simply Not Limited to Diastolic Dysfunction. Cardiovascular therapeutics 2023 (2023)
Xueting Fan, Kai Feng, Yonghui Liu, Leixi Yang, Yizhuo Zhao, Liping Tian, Yiqun Tang, Xiaozhi Wang
miR-135a Regulates Atrial Fibrillation by Targeting Smad3. Cardiovascular therapeutics 2023 (2023)
Muryam Abdul Razzaq, Waqas Younis, Muhammad Nasir Hayat Malik, Tariq G Alsahli, null Alamgeer, Shah Jahan, Roma Ehsan, Arquimedes Gasparotto, Asifa Bashir
Pulegone Prevents Hypertension through Activation of Muscarinic Receptors and Cyclooxygenase Pathway in L-NAME-Induced Hypertensive Rats. Cardiovascular therapeutics 2023 (2023)
Tian-Jun Zhao, Duan Luo, Xi Jiang, Feng Tang, Hui Jiang
Effect of Statins on Major Adverse Cardiovascular Events in Patients with Coronary Artery Spasm: A Meta-Analysis of the Asia Region. Cardiovascular therapeutics 2023 (2023)
Wenyi Zhang, Mingduo Zhang, Jinfan Tian, Min Zhang, Yuan Zhou, Xiantao Song
Drug-Coated Balloon-Only Strategy for De Novo Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials. Cardiovascular therapeutics 2023 (2023)
Zujin Xu, Zhuoran Wei, Yali Zhu, Guoqing Jing, Liufang Chen, Jia Zhan, Yun Wu
Cardioprotection of mAb2G4/ODN/lip on Myocardial Ischemia-Reperfusion Injury via Inhibiting the NF- κ B Signaling Pathway. Cardiovascular therapeutics 2023 (2023)
Tian-Jun Zhao, Duan Luo, Xi Jiang, Feng Tang, Hui Jiang
Effect of Statins on Major Adverse Cardiovascular Events in Patients with Coronary Artery Spasm: A Meta-Analysis of the Asia Region. Cardiovascular therapeutics 2023 (2023)
Maoxia Fan, Guohua Dai, Runmin Li, Xiaoqi Wu
Efficacy of Acupuncture in the Treatment of Essential Hypertension: An Overview of Systematic Reviews and Meta-Analyses. Cardiovascular therapeutics 2023 (2023)
Tian-Jun Zhao, Duan Luo, Xi Jiang, Feng Tang, Hui Jiang
Effect of Statins on Major Adverse Cardiovascular Events in Patients with Coronary Artery Spasm: A Meta-Analysis of the Asia Region. Cardiovascular therapeutics 2023 (2023)
Rui Yang, Yuhong He, Honggang Zhang, Qiuju Zhang, Bingwei Li, Changming Xiong, Yubao Zou, Bingyang Liu
Mass Cytometry Reveals the Imbalanced Immune State in the Peripheral Blood of Patients with Essential Hypertension. Cardiovascular therapeutics 2023 (2023)
Rui Yang, Yuhong He, Honggang Zhang, Qiuju Zhang, Bingwei Li, Changming Xiong, Yubao Zou, Bingyang Liu
Mass Cytometry Reveals the Imbalanced Immune State in the Peripheral Blood of Patients with Essential Hypertension. Cardiovascular therapeutics 2023 (2023)
Anwu Huang, Zhaolin Wang, Hua Tang, Zhuyin Jia, Xiaojun Ji, Xuehua Yang, Wenbing Jiang
Bardoxolone Methyl Ameliorates Myocardial Ischemia/Reperfusion Injury by Activating the Nrf2/HO-1 Signaling Pathway. Cardiovascular therapeutics 2023 (2023)
Junyan Zhang, Zhongxiu Chen, Yujia Cai, Chen Li, Yong He
Comparison of Different Chronic Maintenance Antithrombotic Strategies in Patients with Coronary Artery Disease: A Systematic Review and Network Meta-Analysis. Cardiovascular therapeutics 2023 (2023)
Bohong Zhang, Mingliang He
Identification of Potential Biomarkers for Coronary Artery Disease Based on Cuproptosis. Cardiovascular therapeutics 2023 (2023)
Xiaojing Zhang, Ximin Wu, Huihui Hu, Xiaoping Liu, Zhan-Fang Kang, Xin Deng
DT-010 Exerts Cardioprotective Effects by Regulating the Crosstalk between the AMPK/PGC-1 α Pathway and ERp57. Cardiovascular therapeutics 2023 (2023)
Bohong Zhang, Mingliang He
Identification of Potential Biomarkers for Coronary Artery Disease Based on Cuproptosis. Cardiovascular therapeutics 2023 (2023)
Xiaojing Zhang, Ximin Wu, Huihui Hu, Xiaoping Liu, Zhan-Fang Kang, Xin Deng
DT-010 Exerts Cardioprotective Effects by Regulating the Crosstalk between the AMPK/PGC-1 α Pathway and ERp57. Cardiovascular therapeutics 2023 (2023)
Bohong Zhang, Mingliang He
Identification of Potential Biomarkers for Coronary Artery Disease Based on Cuproptosis. Cardiovascular therapeutics 2023 (2023)
Irmelin I A Biesenbach, Laurits J Heinsen, Katrine S Overgaard, Thomas R Andersen, Søren Auscher, Kenneth Egstrup
The Effect of Clinically Indicated Liraglutide on Pericoronary Adipose Tissue in Type 2 Diabetic Patients. Cardiovascular therapeutics 2023 (2023)
Xiaojing Zhang, Ximin Wu, Huihui Hu, Xiaoping Liu, Zhan-Fang Kang, Xin Deng
DT-010 Exerts Cardioprotective Effects by Regulating the Crosstalk between the AMPK/PGC-1 α Pathway and ERp57. Cardiovascular therapeutics 2023 (2023)